Luminal B breast tumors are not HER2 positive

被引：15

作者：

Bhargava, Rohit ^{[1
]}

Dabbs, David J. ^{[1
]}

机构：

[1] Univ Pittsburgh, Magee Womens Hosp, Med Ctr, Dept Pathol, Pittsburgh, PA 15213 USA

来源：

BREAST CANCER RESEARCH | 2008年 / 10卷 / 05期

关键词：

D O I：

10.1186/bcr2134

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：2

共 13 条

[1]

BAEHNER FL, ASCO BREAST CANC S 2

[2]

BAEHNER FL, 29 ANN SAN ANT BREAS

[3] Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study [J].

Carey, Lisa A. ;

Perou, Charles M. ;

Livasy, Chad A. ;

Dressler, Lynn G. ;

Cowan, David ;

Conway, Kathleen ;

Karaca, Gamze ;

Troester, Melissa A. ;

Tse, Chiu Kit ;

Edmiston, Sharon ;

Deming, Sandra L. ;

Geradts, Joseph ;

Cheang, Maggie C. U. ;

Nielsen, Torsten O. ;

Moorman, Patricia G. ;

Earp, H. Shelton ;

Millikan, Robert C. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (21) :2492-2502

[4] Measurement of gene expression in archival paraffin-embedded tissues - Development and performance of a 92-gene reverse transcriptase-polymerase chain reaction assay [J].

Cronin, M ;

Pho, M ;

Dutta, D ;

Stephans, JC ;

Shak, S ;

Kiefer, MC ;

Esteban, JM ;

Baker, JB .

AMERICAN JOURNAL OF PATHOLOGY, 2004, 164 (01) :35-42

[5]

FLANAGAN MB, 2008, MOD PATHOL

[6] Minimum formalin fixation time for consistent estrogen receptor immunohistochemical staining of invasive breast carcinoma [J].

Goldstein, NS ;

Ferkowicz, M ;

Odish, E ;

Mani, A ;

Hastah, F .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 120 (01) :86-92

[7] Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer [J].

Harvey, JM ;

Clark, GM ;

Osborne, CK ;

Allred, DC .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (05) :1474-1481

[8] Estrogen receptor analysis in primary breast tumors by ligand-binding assay, immmocytochemical assay, and northern blot: a comparison [J].

Lacroix, M ;

Querton, G ;

Hennebert, P ;

Larsimont, D ;

Leclercq, G .

BREAST CANCER RESEARCH AND TREATMENT, 2001, 67 (03) :263-271

[9] HER-2 testing in breast cancer using immunohistochemical analysis and fluorescence in situ hybridization - A single-institution experience of 2,279 cases and comparison of dual-color and single-color scoring [J].

Lal, P ;

Salazar, PA ;

Hudis, CA ;

Ladanyi, M ;

Chen, BY .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 121 (05) :631-636

[10]

MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716

← 1 2 →